Designer Camilla Freeman-Topper tells British Vogue about her life’s mission to end the stigma around ovarian cancer and why her latest capsule collection will help save lives.
Witchery taps into 7 7 million potential customers to help raise funds ragtrader.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ragtrader.com.au Daily Mail and Mail on Sunday newspapers.
Witchery and OCRF announce 2021 White Shirt campaign
April 7, 2021 9:35
Fashion brand Witchery and the Ovarian Cancer Research Foundation have partnered for the 2021 White Shirt campaign.
The announcement:
Leading Australian fashion retailer Witchery and the Ovarian Cancer Research Foundation (OCRF) are honoured to announce the 13th annual White Shirt Campaign in collaboration with renowned fashion designer Toni Maticevski.
For the first time in the history of the campaign, Witchery has collaborated with a designer on the 2021 Witchery White Shirt style.
Melbourne born Maticevski is one of Australia’s most beloved and well-respected fashion creatives, known for his signature tailoring and complex drapery both locally and internationally.
Close×
For the first time in 13 years, Witchery has recruited a designer for its White Shirt Campaign
By Imogen Bailey | 7 April 2021
For the first time in the campaign s 13-year history, Witchery has collaborated with a designer for its 2021 White Shirt Campaign.
The retailer has called on Australian designer Toni Maticevski to help design the shirt, 100% of gross proceeds (from sales) of which will be donated to the Ovarian Cancer Research Foundation (OCRF). It’s a real honour to be able to contribute in my own way to this year’s Witchery White Shirt Campaign, Maticevski said of the partnership. I am surrounded by many beautiful women in my life who provide me with support, strength and protection and in turn, I hope that the shirt I have designed can offer the same to those who are drawn to it.
Credit: The Wistar Institute
PHILADELPHIA (April 1, 2021 Scientists at The Wistar Institute identified a new mechanism of transcriptional control of cellular senescence that drives the release of inflammatory molecules that influence tumor development through altering the surrounding microenvironment. The study, published in
Nature Cell Biology, reports that methyltransferase-like 3 (METTL3) and 14 (METTL14) proteins moonlight as transcriptional regulators that allow for establishment of the senescence-associated secretory phenotype (SASP).
Cellular senescence is a stable state of growth arrest in which cells stop dividing but remain viable and produce an array of inflammatory and growth-promoting molecules collectively defined as SASP. These molecules account for the complex crosstalk between senescent cells and neighboring cells and the effect of cellular senescence in various physiological processes and diseases. Although senescence is regarded as a potent barrier for tum